Prime Medicine, Common Etf Cash Per Share
| PRME Etf | USD 2.00 0.24 13.64% |
Prime Medicine, Common fundamentals help investors to digest information that contributes to Prime Medicine,'s financial success or failures. It also enables traders to predict the movement of Prime Etf. The fundamental analysis module provides a way to measure Prime Medicine,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Prime Medicine, etf.
Prime |
Prime Medicine, Common ETF Cash Per Share Analysis
Prime Medicine,'s Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Prime Medicine, Cash Per Share | 6.39 X |
Most of Prime Medicine,'s fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Prime Medicine, Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
In accordance with the recently published financial statements, Prime Medicine, Common has a Cash Per Share of 6.39 times. This is much higher than that of the Biotechnology family and significantly higher than that of the Health Care category. The cash per share for all United States etfs is notably lower than that of the firm.
Prime Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Prime Medicine,'s direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of Prime Medicine, could also be used in its relative valuation, which is a method of valuing Prime Medicine, by comparing valuation metrics of similar companies.Prime Medicine, is currently under evaluation in cash per share as compared to similar ETFs.
Fund Asset Allocation for Prime Medicine,
The fund invests 99.55% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.Asset allocation divides Prime Medicine,'s investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Prime Fundamentals
| Return On Equity | -1.37 | ||||
| Return On Asset | -0.52 | ||||
| Operating Margin | (20.26) % | ||||
| Current Valuation | 112.67 M | ||||
| Shares Outstanding | 131.16 M | ||||
| Shares Owned By Insiders | 23.90 % | ||||
| Shares Owned By Institutions | 59.05 % | ||||
| Number Of Shares Shorted | 18.06 M | ||||
| Price To Earning | 14.40 X | ||||
| Price To Book | 1.71 X | ||||
| Price To Sales | 88.38 X | ||||
| Revenue | 2.98 M | ||||
| Gross Profit | (152.31 M) | ||||
| EBITDA | (202.47 M) | ||||
| Net Income | (195.88 M) | ||||
| Cash And Equivalents | 146.66 M | ||||
| Cash Per Share | 6.39 X | ||||
| Total Debt | 40.79 M | ||||
| Debt To Equity | 0.18 % | ||||
| Current Ratio | 6.70 X | ||||
| Book Value Per Share | 1.20 X | ||||
| Cash Flow From Operations | (122.86 M) | ||||
| Short Ratio | 17.29 X | ||||
| Earnings Per Share | (1.65) X | ||||
| Target Price | 13.1 | ||||
| Number Of Employees | 214 | ||||
| Beta | 1.85 | ||||
| Market Capitalization | 263.63 M | ||||
| Total Asset | 297.51 M | ||||
| Retained Earnings | (687.21 M) | ||||
| Working Capital | 173.93 M | ||||
| One Year Return | (0.31) % | ||||
| Three Year Return | 3.82 % | ||||
| Net Asset | 297.51 M | ||||
| Equity Positions Weight | 99.55 % |
About Prime Medicine, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Prime Medicine, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Prime Medicine, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Prime Medicine, Common based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Prime Etf
Prime Medicine, financial ratios help investors to determine whether Prime Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Prime with respect to the benefits of owning Prime Medicine, security.